Debu Tripathy
机构:The University of Texas MD Anderson Cancer Center · ORCID:0000-0002-5711-2404
发表论文 1161 篇 · 总被引 26361 次 · h-index 69
代表论文
- IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer (2025 · npj Precision Oncology · 被引 14)
- Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer (2025 · npj Breast Cancer · 被引 3)
- Soluble E-cadherin Drives Brain Metastasis in Inflammatory Breast Cancer (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 3)
- Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer (2025 · JCO Precision Oncology · 被引 2)
- Retrospective review of metastatic hormone receptor-positive inflammatory breast cancer patients reveals poor responses to cyclin dependent kinase 4/6 inhibition (2025 · Breast Cancer Research · 被引 1)
- Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy (2025 · ESMO Open · 被引 1)